Sulforhodamine B (SRB) assay was used to assess the cytotoxicity of newly synthesized compounds against Pgp high-expressing colorectal cancer cell line (LS-174T) over a concentration range 0.01–100 μM. The gene discussed is PGP; the disease is colorectal cancer.